PD Dr. Ralf Linker

Medizinische Fakultät Department of Neurology

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation (2019) Pfeuffer S, Schmidt R, Straeten FA, Pul R, Kleinschnitz C, Wieshuber M, Lee DH, et al. Journal article Siponimod (BAF-312) Attenuates Perihemorrhagic Edema And Improves Survival in Experimental Intracerebral Hemorrhage (2019) Bobinger T, Manaenko A, Burkardt P, Beuscher V, Sprügel M, Röder S, Bäuerle T, et al. Journal article Association of Intrathecal Immunoglobulin G Synthesis with Disability Worsening in Multiple Sclerosis (2019) Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kümpfel T, Linker R, et al. Journal article Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders (2019) Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker R, et al. Journal article Treatment choices and neuropsychological symptoms of a large cohort of early MS (2018) Von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, et al. Journal article Western lifestyle and immunopathology of multiple sclerosis (2018) Matveeva O, Bogie JFJ, Hendriks JJA, Linker R, Haghikia A, Kleinewietfeld M Journal article Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions (2018) Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, et al. Journal article Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice (2018) Haghikia A, Linker R Journal article Vagomimetic Fingolimod effects are compensated by central up-regulation of cardiovagal withdrawal upon rapid blood pressure decrease (2018) Roy S, Wang R, de Rojas Leal C, Liu M, Hoesl K, Lee DH, Linker R, Hilz MJ Conference contribution Mucosal addressin cell adhesion molecule 1 mediated intestinal lymphocyte homing is critical for the development of experimental autoimmune encephalomyelitis (2018) Kuhbandner K, Hammer A, Haase S, Terbrack E, Schippers A, Wagner N, Hussain RZ, et al. Conference contribution